|
Additional information provided in h.6.And h.11.Product evaluation was not able to be performed since the reported product was not received at the investigation site for evaluation.Product is expected but has not been returned to date.Receipt of complaint product or additional information pertinent to this complaint will result in re-evaluation of the complaint investigation.The investigation conducted a non-conformance review of the reported lot number.No deviations that could have contributed to this event were identified and all corresponding production release specifications defined in the device master record were met.Based on the evaluation of the information, the investigation was unable to conclusively identify the root cause or origin of the reported event.Additionally, no manufacturing-related deficiencies were found that potentially could have contributed to the complaint.No further investigative or manufacturing actions are warranted at this time due to the product not being returned to the manufacturing site for testing.Receipt of additional relevant information or supporting materials will prompt a re-evaluation of the complaint investigation.Complaint data for all company products is reviewed monthly to monitor for adverse trends.During the last review, no adverse trends were observed for the reported product and event combination.Quality assurance has reviewed this complaint and will continue to monitor data for evidence of adverse trending and take further action, as appropriate.No further action warranted at this time.The manufacturer internal reference number is: (b)(4).
|
|
Additional information provided in d.9., h.3., h.6.And h.11.Corrected information provided in e.1.(title of initial reporter).The used pak was visually inspected, and no obvious defects were found.The identification (id) tabs and the infusion chamber were intact.The infusion cannula and probe manifold were not returned; lab stocks were used for testing.The returned manifolds, probe connectors, and components were found to be in good condition.The connectors were connected to the cassette and handpiece without any interference.The ball in the drip chamber¿s check valve moved freely per specification.The non-invasive flow sensor (nifs) on the cassette housing was in good condition.The submerge leak test was performed on the cassette.No leakage occurred during generating 200 mmhg (millimeters of mercury) pressure.The product was tested using the console with the current software.The product could prime, tune with the handpiece, the 0.9-millimeter aspiration bypass system (abs) tip from the lab stock and returned infusion sleeve, and pass intraocular pressure (iop) calibration successfully.The product was recognized as correct cassette on the console.Fluid flowed from the balance salt solution (bss) bottle to the drain bag without any interfering.No bubble was observed in the nifs fluid path before the cleaning process.No air leak was detected from the infusion air line during priming process.No message code appeared on the screen.No leakage was detected from the handpiece, infusion manifold, cassette, irrigation/aspiration manifold, connectors, manifolds, pump elastomer or on the pump area of the fluidics module.The cleaning process was able to be performed after functional testing was completed.The product passed functionality per procedure.The investigation conducted a non-conformance review of the reported lot number.No deviations that could have contributed to this event were identified, all corresponding production release specifications defined in the device master record were met.Based on the evaluation of the information and materials received, the investigation was unable to identify the root cause or origin of the reported event as the product functioned per specifications.Additionally, no manufacturing-related deficiencies were found that potentially could have contributed to the complaint.No further investigative or manufacturing actions are warranted at this time due to the product meeting specifications.Receipt of additional relevant information or supporting materials will prompt a re-evaluation of the complaint investigation.Complaint data for all company products is reviewed monthly to monitor for adverse trends.During the last review, no adverse trends were observed for the reported product and event combination.Quality assurance has reviewed this complaint and will continue to monitor data for evidence of adverse trending and take further action, as appropriate.No further action warranted at this time.The manufacturer internal reference number is: (b)(4).
|